Literature DB >> 16765116

Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.

Pim van der Harst1, Adriaan A Voors, Meint Volbeda, Hendrik Buikema, Dirk J van Veldhuisen, Wiek H van Gilst.   

Abstract

High levels of C-reactive protein and soluble intercellular adhesion molecule-1 are associated with increased risk for cardiovascular events. No long-term data are available on predictive value of preoperative levels of C-reactive protein and soluble intercellular adhesion molecule-1 on outcome after coronary artery bypass grafting. We measured baseline levels of C-reactive protein and soluble intercellular adhesion molecule-1 in preoperative serum stored at -80 degrees C in 87 patients with coronary artery disease before undergoing isolated coronary artery bypass grafting. Follow-up was performed after a mean duration of 7.6+/-0.1 years, and all cardiovascular events were recorded. Data were analyzed by categorizing patients into 2 groups according to median value of C-reactive protein and soluble intercellular adhesion molecule-1. During follow-up, 16 patients developed a cardiovascular event. In patients with C-reactive protein above the median (1.9 mg/L), the cumulative cardiovascular event incidence was 29% compared with 9% in patients with levels below the median (p=0.048). In Cox regression analysis that was corrected for age, gender, and conventional risk factors, the adjusted relative risk of cardiovascular events of C-reactive protein above the median was 3.9 (95% confidence interval 1.1 to 13.9, p <0.05). Soluble intercellular adhesion molecule-1 level above the median (136 microg/L) was associated with a cumulative cardiovascular event incidence of 21% versus 16% below the median (p=0.48). In conclusion, in patients who undergo coronary artery bypass grafting, high preoperative levels of C-reactive protein levels, but not of soluble intercellular adhesion molecule-1, were associated with long-term risk of cardiovascular events, independent of other cardiac risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765116     DOI: 10.1016/j.amjcard.2006.01.030

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Telomere biology in healthy aging and disease.

Authors:  Hisko Oeseburg; Rudolf A de Boer; Wiek H van Gilst; Pim van der Harst
Journal:  Pflugers Arch       Date:  2009-09-10       Impact factor: 3.657

Review 2.  The case for statin therapy in chronic heart failure.

Authors:  Pim van der Harst; Michael Böhm; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2007-12-01       Impact factor: 5.460

Review 3.  Aging, telomeres and heart failure.

Authors:  Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

4.  Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: a prospective cohort analytic study.

Authors:  Edgar Hernández-Leiva; Rodolfo Dennis; Daniel Isaza; Juan Pablo Umaña
Journal:  J Cardiothorac Surg       Date:  2013-07-05       Impact factor: 1.637

Review 5.  Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?

Authors:  Alessandro Parolari; Paolo Poggio; Veronika Myasoedova; Paola Songia; Giorgia Bonalumi; Alberto Pilozzi; Davide Pacini; Francesco Alamanni; Elena Tremoli
Journal:  Front Cardiovasc Med       Date:  2016-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.